ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2020

Solid sales growth during November; Zinzino group revenue increased with a total of 36%, compared with the previous year.

The revenue in November for Zinzino's sales markets increased by 35% to SEK 93.7 (69.3) million primarily due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 48% and amounted to SEK 4.3 (2.9) million. Overall, the Group increased revenues by 36% to SEK 98.0 (72.2) million compared with the previous year.

During the last days of November Zinzino’s Black Friday campaign was carried out with a very successful outcome, and a record number of paid orders per day was reached on Saturday 28 November. The outcome of the campaign will primarily be credited during December, when the goods have reached the new customers and distributors.

Accumulated revenue for January – November 2020 increased by 44% SEK 1001.1 (695.4) million.

Revenues distributed as follows:

For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com

Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com

Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the contact person mentioned above for publication at 16:00 the 3rd of December 2020.
 

Zinzino AB (publ.) is a global direct sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS. Zinzino is based in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong and Malaysia. Zinzino is a public limited company and its shares are listed on Nasdaq First North Premier Growth Market.